Business norms of licensed pharmacists
Chapter I General Provisions
Article 1 In order to standardize the business behavior of licensed pharmacists, practice excellent pharmaceutical services, ensure rational drug use by the public, and advocate industry self-discipline, this Code is formulated in accordance with relevant Chinese laws, regulations and policies.
Article 2 This Code is applicable to licensed pharmacists who directly provide pharmaceutical services to the public. Licensed pharmacists should be responsible for the rational use of drugs by the public.
Article 3 The business norms of licensed pharmacists refer to the code of conduct that licensed pharmacists should abide by when using relevant professional knowledge and skills such as pharmacy to engage in business activities.
The business activities of licensed pharmacists include prescription dispensing, medication guidance, medication management, adverse drug reaction monitoring, health education, etc.
Article 4 Licensed pharmacists shall abide by discipline and law, love their posts and respect their work, abide by morality, serve health, consciously learn and improve their abilities, and meet the basic requirements of this Code.
Licensed pharmacists should wear licensed pharmacist badges to show their identity.
Article 5 Licensed pharmacists should master the skills of obtaining medical and health information resources, collect, sort out, summarize and analyze all kinds of valuable information through various channels and tools, and use these information to carry out various business activities.
Article 6 The unit where licensed pharmacists work shall provide necessary conditions for licensed pharmacists to perform this specification, and support and guarantee licensed pharmacists to carry out pharmaceutical services.
Chapter II Prescription Adjustment
Article 7 Prescription adjustment includes prescription review, prescription deployment, review and delivery, and medication instructions. Licensed pharmacists should dispense drugs with doctors' prescriptions, and they may not dispense drugs without doctors' prescriptions.
Prescription dispensing shall comply with the relevant laws, regulations and rules of the state, as well as the basic medical insurance system and other provisions.
Article 8 Prescription audit includes legality audit, normative audit and suitability audit.
Article 9 The review of prescription legality includes prescription source, doctor qualification and prescription category.
Licensed pharmacists may not adjust prescriptions whose legality cannot be judged.
Article 10 The normative review of prescriptions includes item by item checking whether the preface, text and postscript of prescriptions are complete, whether the writing or printing is clear, whether prescriptions are effective, and whether the signature or seal of doctors is consistent with the words used for filing.
Licensed pharmacists are not allowed to adjust non-standard prescriptions.
Article 11 The examination of prescription suitability shall include the following contents:
(1) Whether the prescriber indicates whether the allergy test has been carried out on the drug with skin test, and whether the test result is negative;
(two) whether the prescription medication is consistent with the clinical diagnosis;
(3) Whether the dosage, usage and course of treatment are correct;
(4) Whether the choice of dosage form and route of administration is reasonable;
(five) whether to repeat the administration, especially if the same patient holds more than two prescriptions;
(6) Whether there are potential clinical drug interactions and incompatibility;
(7) Whether there are contraindications for drug use in special groups, such as pregnant women, infants and the elderly. ;
(eight) other circumstances that are not suitable for medication.
For improper prescriptions, the prescriber should be informed and asked to confirm or re-prescribe; Substitute drugs shall not be changed or distributed without authorization.
Twelfth prescription after passing the examination, licensed pharmacists according to the prescription content of drug deployment, deployment should be:
(a) according to the prescription of drugs in order to allocate one by one;
(2) After the drugs are fully prepared, check the drug name, dosage, specification, quantity, usage and dosage with the prescription one by one, and write the label accurately;
(3) Specially managed drugs and high-risk drugs shall be registered in accordance with regulations;
(four) the same patient holds more than two prescriptions, one by one, so as to avoid mistakes;
(five) to prevent confusion in the preparation of drugs, such as drugs with similar names or pronunciations, similar packaging appearance and the same variety and specification;
(6) After mixing, label the drug on the outer package, including name, usage, dosage and storage conditions. ;
Drugs that need special storage conditions shall be labeled or stamped with eye-catching tips.
Thirteenth when preparing Chinese herbal pieces, the dosage should be reduced by the same amount, and the dosage should be repeated one by one. If there are requirements for frying first and then frying, separately frying, separately taking, separately melting and separately frying, it shall be packaged separately, and the usage shall be indicated.
The packaging of Chinese herbal pieces shall indicate the patient's name, dosage, decocting method and matters needing attention.
Article 14 Before delivering drugs, licensed pharmacists should check whether the prepared drugs are consistent with the drugs prescribed by prescriptions, and whether there is any mismatch, omission or overdose.
Fifteenth drug delivery, licensed pharmacists should verify the delivery situation, according to the prescription order one by one to the patient, the patient's family or caregivers, and according to the prescription or doctor's advice to give medication guidance and instructions.
Sixteenth prescription dispensing should implement the system of double check and review of drug dispensing.
A licensed pharmacist shall affix a special seal or signature to the prescription after completing the prescription adjustment.
Article 17 Prescriptions shall be kept for future reference in accordance with regulations.
Chapter III Drug Use Guidance
Eighteenth licensed pharmacists should take the initiative to provide patients with personalized guidance on rational drug use. The contents include:
(1) The name and quantity of the drug;
(2) indications for medication;
(3) Dosage: initial dose and maintenance dose. If necessary, explain how to convert the dose and how to measure it; For drugs used "when necessary", the maximum daily limit should be specified;
(4) Administration method: If there are special requirements for daily administration frequency or interval and course of treatment, especially in the drug instructions, it should be specially explained or demonstrated, and indicated on the drug label if necessary;
(five) the expected time of drug efficacy and the maintenance time of drug efficacy;
(six) the handling methods of forgetting to take or missing drugs, and paying attention to the compliance of patients with drugs;
(seven) how to avoid and deal with the common adverse reactions of drugs;
(eight) methods of self-monitoring the efficacy of drugs;
(nine) other drugs or diets that cannot be used at the same time.
Nineteenth licensed pharmacists to guide patients to use drugs, should do:
(a) to understand the patient's mastery of medical and pharmaceutical knowledge;
(2) Counseling patients on how to use drugs correctly;
(three) to confirm whether the patient has understood the guidance and suggestions;
(four) to remind patients should pay attention to matters.
Twentieth licensed pharmacists have the responsibility and obligation to provide medication advice to patients through direct communication with patients and their families, answer their medication questions, and introduce common sense of drugs and diseases. Licensed pharmacists should do the following when receiving consultation:
(1) Pay attention to etiquette and respect the privacy of patients;
(two) to understand the daily medication of patients and judge the correctness of patients' previous medication;
(3) using popular language;
(four) for the first time, patients with poor drug compliance and patients with low drug use in therapeutic index should provide written guidance materials.
Twenty-first licensed pharmacists have the responsibility and obligation to provide professional guidance to patients or consumers who buy over-the-counter drugs, mainly including:
(1) Ask about recent diseases and medication;
(2) Ask the patient if he has any contraindications or allergic history;
(three) to give advice and guidance to patients in choosing over-the-counter drugs.
Chapter IV Drug Rehabilitation Management
Twenty-second licensed pharmacists should take the initiative to participate in the management of patients' medication, and provide professional services for patients to rationally use drugs and optimize drug efficacy. Drug treatment management includes:
(1) Collect all treatment-related information of patients;
(two) to evaluate and confirm whether there is a problem with the patient's medication;
(three) determine the treatment objectives with patients, formulate intervention measures, and implement pharmaceutical care plans;
(4) Follow-up and further evaluation of the established treatment objectives to ensure that the patients' drug treatment achieves the best effect.
Twenty-third licensed pharmacists who carry out drug treatment management should master communication skills and practical skills of drug treatment evaluation.
Twenty-fourth licensed pharmacists should collect patient-related information and establish a medication calendar on the basis of establishing mutual trust with patients. The collected information includes: the patient's personal basic information, current illness and diagnosis, medication experience, medical history, allergy history, drug treatment plan, etc.
Personal privacy of patients should be protected in communication and recording.
Twenty-fifth licensed pharmacists should evaluate the suitability, effectiveness, safety and medication compliance of patients after collecting patient information.
Drug evaluation includes: judging whether the drugs used by patients are consistent with the indications; Evaluate the treatment effect of patients and confirm whether there are any drug treatment problems. If drug treatment problems are found, they should be solved in order according to the severity and difficulty of drug treatment problems affecting patients. Confirm whether the patient has the ability and willingness to take medicine according to the doctor's advice.
Twenty-sixth licensed pharmacists should establish treatment objectives for each disease of patients and work out pharmaceutical care plans with patients. When necessary, licensed pharmacists should discuss their treatment objectives with patients and their attending physicians to acquire knowledge.
Twenty-seventh licensed pharmacists' intervention measures should be aimed at the individual patient's condition, drug-related needs and drug treatment problems, and make records.
Twenty-eighth licensed pharmacists in the implementation of pharmaceutical care plan, should draw up a timetable for collecting monitoring data, determine the clinical indicators to be monitored, in order to evaluate the drug treatment effect of patients.
In the management of drug treatment, a list of patients' medication should be provided to remind patients to take drugs, and communication should be made with Dr. Yamatonokusushi when visiting a doctor.
Article 29 When tracking and evaluating the curative effect of patients, licensed pharmacists should evaluate the actual treatment results of patients according to the treatment objectives, determine the progress of patients in achieving the treatment objectives, and judge whether there are problems in the safety or medication compliance of patients in drug treatment and whether there are problems in the treatment of new drugs.
Thirtieth drug treatment management records shall include: patient's chief complaint, clinical objective indicators, evaluation of patients' drug treatment problems and the next drug treatment plan. Licensed pharmacists should encourage patients, family members or caregivers to actively participate in the whole process of drug treatment and drug evaluation.
Thirty-first drug treatment management to achieve the goal of treatment as the end point, the whole process must be systematic and sustainable implementation. Licensed pharmacists should strengthen the follow-up of patients who are in the adjustment stage of drug usage and dosage and need special attention to track the drug effect.
Article 32 The key targets of drug rehabilitation management include:
(a) frequent medical treatment or change the treatment plan;
(2) Multi-disciplinary visits or prescriptions issued by multiple doctors;
(3) Suffering from two or more chronic diseases;
(4) Taking more than five kinds of drugs;
(5) Those who are taking high-risk drugs or have poor compliance;
(6) The cost of drug treatment is relatively high.
Chapter V Adverse Drug Reaction Monitoring
Article 33 Licensed pharmacists are responsible for monitoring adverse drug reactions, tracking drug use, and paying special attention to drugs used by special people during the drug monitoring period. When adverse drug reactions are found, they should be recorded and filled in in time, and reported in accordance with the provisions of the Measures for the Administration of Reporting and Monitoring of Adverse Drug Reactions.
Article 34 Licensed pharmacists should pay special attention to the patients' new diseases, carefully observe the patients' clinical symptoms and adverse reactions, and judge whether the patients' new diseases are related to medication. Once found, it should be corrected and reported in time.
Chapter VI Health Education
Thirty-fifth licensed pharmacists have the responsibility and obligation to publicize the knowledge of disease prevention and drug use to the public, actively advocate a healthy lifestyle and promote rational drug use.
Thirty-sixth licensed pharmacists should be providers of community health information to help residents understand the harm of chronic diseases and the importance of preventing chronic diseases.
Thirty-seventh licensed pharmacists should be aware of the national and world health and disease prevention and control publicity day; Pay attention to and study the chronic disease reports regularly issued by the national health administrative department, understand the current situation of chronic diseases in this area, and carry out targeted health education to play a role in preventing and controlling the occurrence and prevalence of chronic diseases.
Thirty-eighth forms of public drug education include:
(a) to carry out lectures on health knowledge related to drug abuse and provide educational materials;
(two) in the community and public places, to provide medication-related education for special people;
(three) the issuance of patient medication consultation contact card. The contact card contains external contact information, working hours, suggestions and consultation contents, and common sense of rational drug use.
Thirty-ninth licensed pharmacists can inform community residents how to correct unhealthy lifestyles (such as weight control, reasonable diet, persistent exercise and smoking cessation) through appropriate forms to prevent and reduce the occurrence of chronic diseases.
Fortieth licensed pharmacists should play an active role in controlling drug abuse.
Strictly implement the special drug management system, and inform drug addicts of their dangers in time when they find them.
Chapter VII Supplementary Provisions
Article 41 This Code is formulated by the Licensed Pharmacist Qualification Certification Center of China Food and Drug Administration, China Pharmaceutical Society, China Pharmaceutical Materials Association, China OTC Pharmaceutical Association and china association of pharmaceutical commerce.
China Food and Drug Administration Licensed Pharmacist Qualification Certification Center is responsible for the interpretation.
Article 42 This Code shall come into force as of the date of 20 17 1+0.
The column of licensed pharmacist examination is recommended to you: